There’s nothing specific to the vaccine in that article. What it’s saying is that there’s a risk of autoimmunity when your immune system develops a response to a protein which is similar to one already in your body. That risk is actually greater with the disease than it is with the vaccine since the vaccine can potentially target proteins dissimilar enough to native proteins that such a response doesn’t happen.
However, when presented with the whole virus, your immune system will trigger off any number of points once identifying the virus as foreign. If the dendritic cells happen to take proteins back to the lymph nodes which are similar enough to those present in your body normally, there’s a risk of autoimmune response. This really comes down to the dendritic cells and what samples are available to them. With the complete virus, it’s a crap shoot. Generation 3 (mRNA platform) vaccines have the opportunity to target proteins not found in the body. We just have to find ones that provoke an immune response, but lack any autoimmune issues.
I understand that it didn’t mention the vaccine specifically but did discuss proteins in the virus and what human protein could be impacted by autoimmunity.
So would autoimmunity of a protein in SARS-COV-2 cause the body to attack itself (aka autoimmune disorder) or cause the body to ignore that protein or cause a over response to future introduction of that protein? That’s the part I’m not sure I follow.
Is the Spike and S protein the same or different? I thought they were effectively the same but this article makes a distinction. I thought the mRNA vaccine was making the spike protein as its component to trigger the immune response.
The vaccine is experimental at this point and pathogenic priming is still a real concern. If you’re interested here’s an important summary on the danger of vaccines and pathogenic priming. Be an educated consumer https://t.co/GwVykfH2dK— Dr. Urso (@richardursomd) January 5, 2021